Changes in Th1/Th2 cytokine balance in Graves' desease
- PMID: 28008495
- DOI: 10.1007/s004240000019
Changes in Th1/Th2 cytokine balance in Graves' desease
Abstract
Graves' disease (GD) is characterised by hyperthyroidism, caused by stimulatory thyrotropin receptor (TSHR) antibodies. Recent research shows that an important factor in the pathogenesis of autoimmune diseases is the change in the balance between Th1 cytokines, which promote cell mediated immunity, and Th2 cytokines, which promote humoral immunity. There are contradictory data about this balance shift in GD. Our objective was to determine the Th1/Th2 cytokine balance shift in patients with newly diagnosed GD, when compared to the same balance in healthy controls. We isolated mononuclear cells (MNC) from the peripheral blood of healthy donors and from patients with newly diagnosed GD before treatment. The MNC were activated with ionomycin in combination with phorbol 12-myristate 13-acetate (PMA). After 40-hour incubation, the concentrations of the cytokines produced (IFN-γ, IL-4, IL-10, IL-12) in the culture supernatants were measured by ELISA (Endogen, USA). The MNC cultures from patients with GD produced significantly less IL-12 and significantly more IL-10 and IL-4 than MNC cultures from healthy controls. All calculated ratios of Th1 against Th2 cytokines in MNC cultures from patients with GD were significantly lower than in MNC cultures from healthy controls. Our results show a systemic shift of cytokine production in patients with GD toward the Th2 cytokine response, thus confirming the key role of TSHR antibodies and humoral immunity in the pathogenesis of GD.
Keywords: Ionomycin; Key words Graves’ disease; Mononuclear cells; Phorbol myristate acetate; Th1/Th2 cytokine balance.
Similar articles
-
Changes in Th1/Th2 cytokine balance in Graves' disease.Pflugers Arch. 2000;440(5 Suppl):R94-5. Pflugers Arch. 2000. PMID: 11005626
-
Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.J Endocrinol Invest. 2004 Apr;27(4):302-7. doi: 10.1007/BF03351052. J Endocrinol Invest. 2004. PMID: 15233546
-
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.Diabetes. 1997 Feb;46(2):237-43. doi: 10.2337/diab.46.2.237. Diabetes. 1997. PMID: 9000700
-
Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.Dan Med J. 2016 Feb;63(2):B5177. Dan Med J. 2016. PMID: 26836805 Review.
-
[A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].Rinsho Byori. 1998 Sep;46(9):915-21. Rinsho Byori. 1998. PMID: 9800477 Review. Japanese.
Cited by
-
SLAM/SAP Decreased Follicular Regulatory T Cells in Patients with Graves' Disease.J Immunol Res. 2021 Apr 19;2021:5548463. doi: 10.1155/2021/5548463. eCollection 2021. J Immunol Res. 2021. PMID: 33987447 Free PMC article.
-
A refined study of FCRL genes from a genome-wide association study for Graves' disease.PLoS One. 2013;8(3):e57758. doi: 10.1371/journal.pone.0057758. Epub 2013 Mar 7. PLoS One. 2013. PMID: 23505439 Free PMC article.
-
CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.Pathogens. 2022 Jul 25;11(8):831. doi: 10.3390/pathogens11080831. Pathogens. 2022. PMID: 35894054 Free PMC article. Review.
-
Characterizing the Interplay of Lymphocytes in Graves' Disease.Int J Mol Sci. 2023 Apr 6;24(7):6835. doi: 10.3390/ijms24076835. Int J Mol Sci. 2023. PMID: 37047805 Free PMC article. Review.
LinkOut - more resources
Full Text Sources